Thrive Bioscience, Inc.
Beverly, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Thrive Bioscience, Inc.
Sign up to see every warm intro you have to Thrive Bioscience, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Thrive Bioscience, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Thrive Bioscience develops the Thrive IQ software platform and CellAssist imaging systems that capture and analyze time-series morphological data on live cells, colonies, and organoids in culture. Its products produce ML/AI-ready phenotypic data sets for biologists and data scientists working in cell biology and bioprocessing.
Founders & leadership


Investors · 1
Reported raises · per SEC filings
Form D private placements$14.4M disclosed across 4 rounds · 2015–2017
▶$1.8MraisedAug 2017 · 21 investors · BiotechnologyRule 506(b)
- Thomas Forest FarbExecutive Officer, Director
- Michael FinneyDirector
- Brock ReeveDirector
- Alan Philippe BlanchardExecutive Officer, Director
- Guy BroadbentDirector
- Offering amount
- $2.5M
- Amount sold
- $1.8M
- Minimum investment
- $100K
- Proceeds to insiders
- $264K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7.2MraisedMar 2017 · 36 investors · BiotechnologyRule 506(b)
- Alan Philippe BlanchardExecutive Officer, Director
- Michael FinneyDirector
- Thomas Forest FarbExecutive Officer, Director
- Brock ReeveDirector
- Guy BroadbentDirector
- Offering amount
- $10M
- Amount sold
- $7.2M
- Minimum investment
- $7.5K
- Proceeds to insiders
- $760K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedDec 2015 · 20 investors · BiotechnologyRule 506(b)
- Alan Philippe BlanchardExecutive Officer, Director
- Michael FinneyDirector
- Thomas Forest FarbExecutive Officer, Director
- Brock ReeveDirector
- Guy BroadbentDirector
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- Minimum investment
- $7.5K
- Proceeds to insiders
- $350K
- First sale
- Nov 2015
- Incorporated
- Corporation, Massachusetts, 2014
- Federal exemptions
- 06b
▶$3.3MraisedMay 2015 · 24 investors · BiotechnologyRule 506(b)
- Thomas Forest FarbExecutive Officer, Director
- Michael Forest FinneyDirector
- Gary Paul MagnantExecutive Officer, Director
- Alan Philippe BlanchardExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.3M
- Minimum investment
- $20K
- Proceeds to insiders
- $285K
- First sale
- Apr 2015
- Incorporated
- Corporation, Massachusetts, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through Thrive Bioscience, Inc. went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Thrive Bioscience, Inc..
Frequently asked questions
- What does Thrive Bioscience, Inc. do?
- Thrive Bioscience develops the Thrive IQ software platform and CellAssist imaging systems that capture and analyze time-series morphological data on live cells, colonies, and organoids in culture. Its products produce ML/AI-ready phenotypic data sets for biologists and data scientists working in cell biology and bioprocessing.
- Who are Thrive Bioscience, Inc.'s investors?
- Thrive Bioscience, Inc.'s investors include Lauder Partners.
- How much funding has Thrive Bioscience, Inc. raised?
- Thrive Bioscience, Inc. has disclosed $14.4M raised across 4 rounds.
- Where is Thrive Bioscience, Inc. headquartered?
- Thrive Bioscience, Inc. is headquartered in Beverly, US.



